These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 10361491

  • 1. What you need to know--hearing loss and inner ear diseases--can they be cured?
    Ruan RS, Soh KB, Yeoh KH.
    Singapore Med J; 1999 Jan; 40(1):60-1. PubMed ID: 10361491
    [No Abstract] [Full Text] [Related]

  • 2. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study.
    Matteson EL, Choi HK, Poe DS, Wise C, Lowe VJ, McDonald TJ, Rahman MU.
    Arthritis Rheum; 2005 Jun 15; 53(3):337-42. PubMed ID: 15934127
    [Abstract] [Full Text] [Related]

  • 3. [Autoimmune disease of the inner ear].
    Cinco Balderas E, Paquot Chico RO, López Ríos G, Kim ML.
    Gac Med Mex; 1992 Jun 15; 128(3):271-4. PubMed ID: 1302729
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The use of glucuronyl glucosamine glycan sulfate in dyslipidemic subjects with labyrinth disease].
    Serra A, Vancheri M, Di Mauro A.
    G Clin Med; 1980 Dec 15; 61(12):919-27. PubMed ID: 7215740
    [No Abstract] [Full Text] [Related]

  • 10. Autoimmune inner ear disease: results of therapy.
    McCabe BF.
    Adv Otorhinolaryngol; 1991 Dec 15; 46():78-81. PubMed ID: 1927720
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Validity of the Western blot immunoassay for heat shock protein-70 in associated and isolated immunorelated inner ear disease.
    García Berrocal JR, Ramírez-Camacho R, Arellano B, Vargas JA.
    Laryngoscope; 2002 Feb 15; 112(2):304-9. PubMed ID: 11889388
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pediatric fluctuating sensorineural hearing loss: problems in medical management.
    Dinces EA, Yang S, Balogun AO.
    Laryngoscope; 2001 Jan 15; 111(1):21-5. PubMed ID: 11192894
    [Abstract] [Full Text] [Related]

  • 17. Recent advances in therapeutics and drug delivery for the treatment of inner ear diseases: a patent review (2011-2015).
    Nguyen K, Kempfle JS, Jung DH, McKenna CE.
    Expert Opin Ther Pat; 2017 Feb 15; 27(2):191-202. PubMed ID: 27855527
    [Abstract] [Full Text] [Related]

  • 18. [Cogan I syndrome. Audio-vestibular, ophthalmologic findings and therapy in 6 patients].
    Bohndorf M, Baykal HE, Plinkert PK, Pleyer U.
    HNO; 1996 Jun 15; 44(6):302-6. PubMed ID: 8767125
    [Abstract] [Full Text] [Related]

  • 19. The autoimmune characteristics of progressive or sudden sensorineural hearing loss.
    Yehudai D, Shoenfeld Y, Toubi E.
    Autoimmunity; 2006 Mar 15; 39(2):153-8. PubMed ID: 16698672
    [Abstract] [Full Text] [Related]

  • 20. Immune-mediated inner ear disease.
    Bovo R, Aimoni C, Martini A.
    Acta Otolaryngol; 2006 Oct 15; 126(10):1012-21. PubMed ID: 16923703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.